About Us

button

button

Our activities can be broadly divided into two categories: cosmetics and pharmaceuticals. In the area of cosmetics, we distribute cosmetic material and products; in the pharmaceutical sector, we pursue research and development of candidate substances of novelty pharmaceuticals.

button

SANSHO Co. has been founded by President Morohoshi to provide the society with benefits from research results by Prof. Murofushi's, with whom the president has been working in joint research for more than twenty years. Having seen an unknown amount of potential in this biological, cPA, which was discovered by Prof. Murofushi, President Morohoshi decided to set up a business entity to make this compound known to the world. Currently, SANSHO is pushing forward with patenting and commercializing novel compounds, including cyclic lysophosphatidic acid Na (NcPA) and 2-carbocyclic phosphatidic acid (2ccPA), both of which are Dr. Murofushi's discoveries.

button

Dr. Kato, former professor at the College of Pharmacy of Toho University for many years, was enthusiastically involved in the research of actinomycetes in the college microbiology class. Actinomycetes produce such a large number of substances that they are called, among all microorganisms, a repository of physiologically active substances. Well known ones include streptomycin, antitubercular agent used in today's medical practice, besides many other types available. Actinomycetes, which produce these antibiotics, are useful microorganisms for humans. Dr. Kato and President Morohoshi studied in the same university with the same teachers, and they have been co-researchers for many years.

button

button

We distribute a cosmetic line, "Grace."
http://www.c-pa.jp/

button

We distribute cyclic lysophosphatidic acid Na (NcPA).
http://sanshopharma.co.jp/en/work_make/index.html

button

NcPA, a small-molecular-weight lipid, activates fibroblasts by directly acting on them. Its expected effects include promotion of hyaluronan synthesis, strengthening of collagen, increase in aquaporin 3, improvement in barrier function, fortification of cytoskeleton, and inhibition of atopic dermatitis [patent number 5737888].
http://sanshopharma.co.jp/en/pdf/common/experimentation.pdf

button

We, SANSHO Co., holds the process patent for NcPA, and we are the manufacturer.

button

NcPA has been developed based on research of cPA and is manufactured by SANSHO as cosmetic material. It is a sodium salt as its name, cyclic lysophosphatidic acid Na, indicates. cPA, which stands for cyclic phosphatidic acid, was first discovered in the world in 1985 by Prof. Kimiko Murofushi after isolation from cellular slime mold. There are many presentations made at academic meetings and published articles about cPA.

button

Considering your preference, we can negotiate about the minimum order quantity. So, please feel free to contact us. We usually sell in units of 100 grams.

button

Of course. Please feel free to ask.

button

Yes, we do. There are overseas cosmetics companies that distribute products containing NcPA. We can ship NcPA overseas. Please contact us.